Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 3 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 13 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
MYPHARMA from Peer, company number BE0788300093, closed financial year 2025 with a result of € -2,410 after tax. For that financial year MYPHARMA recorded a gross margin of € -1,889 and equity of € -5,839. Compared with financial year 2024, the result moved from € -1,659 to € -2,410. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.
€ -5,839
▼ € 2,410 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2,410
▼ 45 % more loss than in 2024
Profit after tax over the fiscal year.
€ 208
▼ 13% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -6,839.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 400
No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 30
▼ 36% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | - | € -1,964 | € -1,567 | € -1,889 | ▼ € 322 |
| Profit after taxes | € -347 | € -2,423 | € -1,659 | € -2,410 | ▼ € 752 |
| Equity | € 653 | € -1,770 | € -3,429 | € -5,839 | ▼ € 2,410 |
| Total debts | € 0 | € 2,192 | € 4,041 | € 6,722 | ▲ 66% |
| Cash | € 653 | € 268 | € 238 | € 208 | ▼ 13% |
| Retained profit | € -347 | € -2,770 | € -4,429 | € -6,839 | ▼ € 2,410 |
| Balance sheet total | € 653 | € 422 | € 612 | € 883 | ▲ 44% |
Key figures of MYPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MYPHARMA?
What happened at MYPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 2,410. filed late Source: NBB ↗
- New establishment in Peer. KBO
- Start of the company according to the CBE. KBO
In short
From € 348 loss in 2022 to € 2,410 loss in 2025.
Management
Behind MYPHARMA is Patrick, Peter, Robert MEYSEN. Patrick, Peter, Robert MEYSEN is also behind APOTHEEK PATRICK MEYSEN.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Markt 22
3990 Peer
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Website info
Features
Security
Network
Details
- Company number
- 0788.300.093
- VAT number
- BE 0788.300.093
- Registered office
- Markt 22, 3990 Peer
- Names & denominations
- MYPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 July 2022
- Peppol
- Active · Active since 1 Dec 2025
- Contact
- mypharma.be [email protected] 0495278690
- Activities · NACE
Ontwerpen van computerprogramma’s
Ontwerpen en programmeren van computerprogramma's
Activiteiten van webportalen
Webportalen